These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 24961436)

  • 1. Impact of indication-shift of primary and adjuvant chemo radiation in advanced laryngeal and hypopharyngeal squamous cell carcinoma.
    Boehm A; Lindner F; Wichmann G; Bauer U; Wittekind C; Knoedler M; Lordick F; Dietzsch S; Scholz M; Kortmann R; Dietz A
    Eur Arch Otorhinolaryngol; 2015 Aug; 272(8):2017-25. PubMed ID: 24961436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved survival of locoregional-advanced larynx and hypopharynx cancer patients treated according to the DeLOS-II protocol.
    Wichmann G; Wald T; Pirlich M; Stoehr M; Zebralla V; Kuhnt T; Nicolay NH; Hambsch P; Krücken I; Hoffmann KT; Lordick F; Kluge R; Wiegand S; Dietz A
    Front Oncol; 2024; 14():1394691. PubMed ID: 38919522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx.
    Spector JG; Sessions DG; Haughey BH; Chao KS; Simpson J; El Mofty S; Perez CA
    Laryngoscope; 2001 Jun; 111(6):1079-87. PubMed ID: 11404625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A phase 2 trial of surgery with perioperative INGN 201 (Ad5CMV-p53) gene therapy followed by chemoradiotherapy for advanced, resectable squamous cell carcinoma of the oral cavity, oropharynx, hypopharynx, and larynx: report of the Southwest Oncology Group.
    Yoo GH; Moon J; Leblanc M; Lonardo F; Urba S; Kim H; Hanna E; Tsue T; Valentino J; Ensley J; Wolf G
    Arch Otolaryngol Head Neck Surg; 2009 Sep; 135(9):869-74. PubMed ID: 19770418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postoperative (chemo) radiation in patients with squamous cell cancers of the head and neck - clinical results from the cohort of the clinical cooperation group "Personalized Radiotherapy in Head and Neck Cancer".
    Maihoefer C; Schüttrumpf L; Macht C; Pflugradt U; Hess J; Schneider L; Woischke C; Walch A; Baumeister P; Kirchner T; Zitzelsberger H; Belka C; Ganswindt U
    Radiat Oncol; 2018 Jul; 13(1):123. PubMed ID: 29970111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of cisplatin dose intensity on human papillomavirus-related and -unrelated locally advanced head and neck squamous cell carcinoma.
    Spreafico A; Huang SH; Xu W; Granata R; Liu CS; Waldron JN; Chen E; Ringash J; Bayley A; Chan KK; Hope AJ; Cho J; Razak AA; Hansen A; Jang R; Perez-Ordonez B; Weinreb I; Bossi P; Orlandi E; Licitra LF; Song Y; O'Sullivan B; Siu LL; Kim J
    Eur J Cancer; 2016 Nov; 67():174-182. PubMed ID: 27669504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of advanced hypopharyngeal and laryngeal cancer with and without cartilage invasion.
    Scherl C; Mantsopoulos K; Semrau S; Fietkau R; Kapsreiter M; Koch M; Traxdorf M; Grundtner P; Iro H
    Auris Nasus Larynx; 2017 Jun; 44(3):333-339. PubMed ID: 27569289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laryngeal preservation by induction chemotherapy plus radiotherapy in locally advanced head and neck cancer: the M. D. Anderson Cancer Center experience.
    Shirinian MH; Weber RS; Lippman SM; Dimery IW; Earley CL; Garden AS; Michaelson J; Morrison WH; Kramer A; Byers R
    Head Neck; 1994; 16(1):39-44. PubMed ID: 7510276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Larynx preservation using induction chemotherapy plus radiation therapy as an alternative to laryngectomy in advanced head and neck cancer. A long-term follow-up report.
    Karp DD; Vaughan CW; Carter R; Willett B; Heeren T; Calarese P; Zeitels S; Strong MS; Hong WK
    Am J Clin Oncol; 1991 Aug; 14(4):273-9. PubMed ID: 1713738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant Chemoradiation After Surgical Resection in Elderly Patients With High-Risk Squamous Cell Carcinoma of the Head and Neck: A National Cancer Database Analysis.
    Woody NM; Ward MC; Koyfman SA; Reddy CA; Geiger J; Joshi N; Burkey B; Scharpf J; Lamarre E; Prendes B; Adelstein DJ
    Int J Radiat Oncol Biol Phys; 2017 Jul; 98(4):784-792. PubMed ID: 28602410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pathomorphological aspects of transoral resection of hypopharyngeal carcinoma with preservation of the larynx. Patient selection, treatment results].
    Glanz H
    Laryngorhinootologie; 1999 Dec; 78(12):654-62. PubMed ID: 10666691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction chemotherapy with cisplatin and 5-fluorouracil followed by chemoradiotherapy or radiotherapy alone in the treatment of locoregionally advanced resectable cancers of the larynx and hypopharynx: results of single-center study of 45 patients.
    Altundag O; Gullu I; Altundag K; Yalcin S; Ozyar E; Cengiz M; Akyol F; Yucel T; Hosal S; Sozeri B
    Head Neck; 2005 Jan; 27(1):15-21. PubMed ID: 15515158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of induction chemotherapy followed by surgery in unresectable stage IVb laryngeal and hypopharyngeal cancers: a case series.
    Sittitrai P; Reunmarkkaew D; Chaiyasate S
    J Otolaryngol Head Neck Surg; 2018 Oct; 47(1):62. PubMed ID: 30326958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized trial of radiation therapy compared to split course radiation therapy combined with mitomycin C and 5 fluorouracil as initial treatment for advanced laryngeal and hypopharyngeal squamous carcinoma.
    Keane TJ; Cummings BJ; O'Sullivan B; Payne D; Rawlinson E; MacKenzie R; Danjoux C; Hodson I
    Int J Radiat Oncol Biol Phys; 1993 Mar; 25(4):613-8. PubMed ID: 8454478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Squamous cell carcinoma of the hypopharynx and larynx: evidence-based care].
    Fayette J; Pointreau Y; Bourhis J; Lefebvre JL
    Bull Cancer; 2014 May; 101(5):438-44. PubMed ID: 24886894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of concomitant chemoradiation on survival for patients with T1-2N1 head and neck cancer.
    Zumsteg ZS; Kim S; David JM; Yoshida EJ; Tighiouart M; Shiao SL; Scher K; Mita A; Sherman EJ; Lee NY; Ho AS
    Cancer; 2017 May; 123(9):1555-1565. PubMed ID: 28001302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II trial of chemoradiation for organ preservation in resectable stage III or IV squamous cell carcinomas of the larynx or oropharynx: results of Eastern Cooperative Oncology Group Study E2399.
    Cmelak AJ; Li S; Goldwasser MA; Murphy B; Cannon M; Pinto H; Rosenthal DI; Gillison M; Forastiere AA
    J Clin Oncol; 2007 Sep; 25(25):3971-7. PubMed ID: 17761982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Long-term outcome of patients with pyriform sinus squamous cell carcinoma treated with planned preoperative (chemo-) radiotherapy plus laryngeal function sparing surgery].
    Huang H; Zhang ZM; Zhang Y; Wang XL; Liu SY; Xu ZG
    Zhonghua Zhong Liu Za Zhi; 2019 Jul; 41(7):535-539. PubMed ID: 31357842
    [No Abstract]   [Full Text] [Related]  

  • 19. Larynx preservation with combined chemotherapy and radiation therapy in advanced but resectable head and neck cancer.
    Pfister DG; Strong E; Harrison L; Haines IE; Pfister DA; Sessions R; Spiro R; Shah J; Gerold F; McLure T
    J Clin Oncol; 1991 May; 9(5):850-9. PubMed ID: 2016629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality of life in patients treated for advanced hypopharyngeal or laryngeal cancer.
    Guibert M; Lepage B; Woisard V; Rives M; Serrano E; Vergez S
    Eur Ann Otorhinolaryngol Head Neck Dis; 2011 Nov; 128(5):218-23. PubMed ID: 21613002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.